Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001123292-24-000417·Skorpios Trust
Schedule 13D ownership disclosure
Stoke Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 86150R107
Event date: 2024-12-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Blue Horizon Enterprise Ltd.
Shares: 2,967,621 · Class: 5.6%
- Ezbon International Limited
Shares: 3,938,560 · Class: 7.4%
- Montrago Trustees Limited
Shares: 6,906,181 · Class: 13%
- Skorpios TrustReported CIK 0001869333
Shares: 6,906,181 · Class: 13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-24-000417
- Form type
- SCHEDULE 13D/A
- Filer
- Skorpios Trust
- CIK
- CIK 1869333
- Filed
- Dec 27, 2024
- Reporting period
- Dec 23, 2024
- Description
- Schedule 13D beneficial ownership